Zhongming Qiu
Clinical trials sponsored by Zhongming Qiu, explained in plain language.
-
New drug ripertamab tested for muscle weakness disease
Disease control Not yet recruitingThis early-phase trial tests if ripertamab can improve symptoms of generalized myasthenia gravis, a disease causing muscle weakness. About 20 adults with confirmed disease will receive a single infusion of ripertamab or a placebo. Researchers will track symptom changes and side e…
Phase: PHASE1, PHASE2 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New hope for rare muscle disease: drug trial launches
Disease control Not yet recruitingThis study tests a drug called telitacicept in 30 adults with inflammatory myopathy, a condition where the immune system attacks muscles, causing weakness. The goal is to see if the drug is safe and can control the disease in people who haven't improved with standard treatments. …
Phase: PHASE2, PHASE3 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC